Subcutaneous efgartigimod PH20 SC is effective and tolerable for the treatment of CIDP, providing a convenient alternative to intravenous and other older treatments.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/998117?src=rss
Author :
Publish date : 2023-11-06 18:20:54
Copyright for syndicated content belongs to the linked Source.